nodes	percent_of_prediction	percent_of_DWPC	metapath
Entacapone—Parkinson's disease—Clonazepam—epilepsy syndrome	0.268	0.554	CpDpCtD
Entacapone—Parkinson's disease—Gabapentin—epilepsy syndrome	0.216	0.446	CpDpCtD
Entacapone—UGT1A9—Propofol—epilepsy syndrome	0.145	0.583	CbGbCtD
Entacapone—UGT1A9—Valproic Acid—epilepsy syndrome	0.103	0.417	CbGbCtD
Entacapone—COMT—telencephalic ventricle—epilepsy syndrome	0.00361	0.278	CbGeAlD
Entacapone—COMT—ganglion—epilepsy syndrome	0.00225	0.173	CbGeAlD
Entacapone—COMT—brainstem—epilepsy syndrome	0.000977	0.0753	CbGeAlD
Entacapone—COMT—forebrain—epilepsy syndrome	0.000943	0.0727	CbGeAlD
Entacapone—COMT—telencephalon—epilepsy syndrome	0.000867	0.0668	CbGeAlD
Entacapone—COMT—medulla oblongata—epilepsy syndrome	0.000681	0.0525	CbGeAlD
Entacapone—COMT—midbrain—epilepsy syndrome	0.000623	0.048	CbGeAlD
Entacapone—COMT—spinal cord—epilepsy syndrome	0.000608	0.0468	CbGeAlD
Entacapone—COMT—head—epilepsy syndrome	0.00054	0.0416	CbGeAlD
Entacapone—COMT—nervous system—epilepsy syndrome	0.000512	0.0395	CbGeAlD
Entacapone—COMT—central nervous system—epilepsy syndrome	0.000493	0.038	CbGeAlD
Entacapone—COMT—cerebellum—epilepsy syndrome	0.000482	0.0371	CbGeAlD
Entacapone—COMT—brain—epilepsy syndrome	0.000391	0.0302	CbGeAlD
Entacapone—COMT—Neuronal System—KCNK3—epilepsy syndrome	0.000362	0.00752	CbGpPWpGaD
Entacapone—UGT1A9—Metapathway biotransformation—KCNAB2—epilepsy syndrome	0.000345	0.00715	CbGpPWpGaD
Entacapone—COMT—Neuronal System—KCNV1—epilepsy syndrome	0.000337	0.00699	CbGpPWpGaD
Entacapone—COMT—Neuronal System—CACNG2—epilepsy syndrome	0.000337	0.00699	CbGpPWpGaD
Entacapone—COMT—Neuronal System—HCN1—epilepsy syndrome	0.000337	0.00699	CbGpPWpGaD
Entacapone—COMT—Neuronal System—KCNQ2—epilepsy syndrome	0.000317	0.00657	CbGpPWpGaD
Entacapone—COMT—Neuronal System—CHRNA2—epilepsy syndrome	0.000317	0.00657	CbGpPWpGaD
Entacapone—COMT—Neuronal System—KCNQ3—epilepsy syndrome	0.000317	0.00657	CbGpPWpGaD
Entacapone—COMT—Transmission across Chemical Synapses—SYN1—epilepsy syndrome	0.000313	0.0065	CbGpPWpGaD
Entacapone—COMT—Transmission across Chemical Synapses—NSF—epilepsy syndrome	0.000313	0.0065	CbGpPWpGaD
Entacapone—COMT—Transmission across Chemical Synapses—STXBP1—epilepsy syndrome	0.000305	0.00632	CbGpPWpGaD
Entacapone—UGT1A9—NRF2 pathway—SLC6A8—epilepsy syndrome	0.000302	0.00627	CbGpPWpGaD
Entacapone—COMT—Neuronal System—KCNB1—epilepsy syndrome	0.0003	0.00623	CbGpPWpGaD
Entacapone—COMT—Neuronal System—CACNA2D2—epilepsy syndrome	0.0003	0.00623	CbGpPWpGaD
Entacapone—COMT—Neuronal System—CACNB4—epilepsy syndrome	0.0003	0.00623	CbGpPWpGaD
Entacapone—COMT—Transmission across Chemical Synapses—SLC1A1—epilepsy syndrome	0.000297	0.00616	CbGpPWpGaD
Entacapone—COMT—Neuronal System—GABRG2—epilepsy syndrome	0.000286	0.00594	CbGpPWpGaD
Entacapone—COMT—Neuronal System—KCNH1—epilepsy syndrome	0.000286	0.00594	CbGpPWpGaD
Entacapone—UGT1A9—Constitutive Androstane Receptor Pathway—ABCB1—epilepsy syndrome	0.000283	0.00588	CbGpPWpGaD
Entacapone—COMT—Transmission across Chemical Synapses—CACNA1A—epilepsy syndrome	0.000283	0.00588	CbGpPWpGaD
Entacapone—COMT—Transmission across Chemical Synapses—GRIA4—epilepsy syndrome	0.000283	0.00588	CbGpPWpGaD
Entacapone—COMT—Transmission across Chemical Synapses—ABAT—epilepsy syndrome	0.000283	0.00588	CbGpPWpGaD
Entacapone—COMT—Transmission across Chemical Synapses—GABRA5—epilepsy syndrome	0.000283	0.00588	CbGpPWpGaD
Entacapone—COMT—Transmission across Chemical Synapses—KCNJ10—epilepsy syndrome	0.000283	0.00588	CbGpPWpGaD
Entacapone—COMT—Transmission across Chemical Synapses—GABRA1—epilepsy syndrome	0.000272	0.00564	CbGpPWpGaD
Entacapone—COMT—Transmission across Chemical Synapses—SLC17A7—epilepsy syndrome	0.000272	0.00564	CbGpPWpGaD
Entacapone—COMT—Transmission across Chemical Synapses—GABRB3—epilepsy syndrome	0.000272	0.00564	CbGpPWpGaD
Entacapone—COMT—Transmission across Chemical Synapses—ARHGEF9—epilepsy syndrome	0.000272	0.00564	CbGpPWpGaD
Entacapone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—JUNB—epilepsy syndrome	0.000267	0.00553	CbGpPWpGaD
Entacapone—COMT—Transmission across Chemical Synapses—GLUL—epilepsy syndrome	0.000266	0.00553	CbGpPWpGaD
Entacapone—COMT—Transmission across Chemical Synapses—GRIA2—epilepsy syndrome	0.000261	0.00542	CbGpPWpGaD
Entacapone—COMT—Transmission across Chemical Synapses—GRIK1—epilepsy syndrome	0.000253	0.00524	CbGpPWpGaD
Entacapone—COMT—Transmission across Chemical Synapses—CHRNA7—epilepsy syndrome	0.000253	0.00524	CbGpPWpGaD
Entacapone—COMT—Transmission across Chemical Synapses—SLC1A2—epilepsy syndrome	0.000253	0.00524	CbGpPWpGaD
Entacapone—COMT—Transmission across Chemical Synapses—GABRB2—epilepsy syndrome	0.000241	0.005	CbGpPWpGaD
Entacapone—COMT—Neuronal System—NSF—epilepsy syndrome	0.00024	0.00498	CbGpPWpGaD
Entacapone—COMT—Neuronal System—SYN1—epilepsy syndrome	0.00024	0.00498	CbGpPWpGaD
Entacapone—COMT—Transmission across Chemical Synapses—GAD2—epilepsy syndrome	0.000237	0.00493	CbGpPWpGaD
Entacapone—UGT1A9—PPARA activates gene expression—TXNRD1—epilepsy syndrome	0.000236	0.0049	CbGpPWpGaD
Entacapone—COMT—Neuronal System—STXBP1—epilepsy syndrome	0.000233	0.00484	CbGpPWpGaD
Entacapone—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—TXNRD1—epilepsy syndrome	0.000231	0.0048	CbGpPWpGaD
Entacapone—COMT—Neuronal System—SLC1A1—epilepsy syndrome	0.000228	0.00472	CbGpPWpGaD
Entacapone—COMT—Neuronal System—GRIA4—epilepsy syndrome	0.000217	0.0045	CbGpPWpGaD
Entacapone—COMT—Neuronal System—CACNA1A—epilepsy syndrome	0.000217	0.0045	CbGpPWpGaD
Entacapone—COMT—Neuronal System—GABRA5—epilepsy syndrome	0.000217	0.0045	CbGpPWpGaD
Entacapone—COMT—Neuronal System—ABAT—epilepsy syndrome	0.000217	0.0045	CbGpPWpGaD
Entacapone—COMT—Neuronal System—KCNJ10—epilepsy syndrome	0.000217	0.0045	CbGpPWpGaD
Entacapone—COMT—Transmission across Chemical Synapses—SLC1A3—epilepsy syndrome	0.000215	0.00445	CbGpPWpGaD
Entacapone—COMT—Transmission across Chemical Synapses—GRIK2—epilepsy syndrome	0.000215	0.00445	CbGpPWpGaD
Entacapone—COMT—Neuronal System—GABRA1—epilepsy syndrome	0.000208	0.00432	CbGpPWpGaD
Entacapone—COMT—Neuronal System—GABRB3—epilepsy syndrome	0.000208	0.00432	CbGpPWpGaD
Entacapone—COMT—Neuronal System—SLC17A7—epilepsy syndrome	0.000208	0.00432	CbGpPWpGaD
Entacapone—COMT—Neuronal System—ARHGEF9—epilepsy syndrome	0.000208	0.00432	CbGpPWpGaD
Entacapone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—HES1—epilepsy syndrome	0.000207	0.0043	CbGpPWpGaD
Entacapone—COMT—Transmission across Chemical Synapses—GAD1—epilepsy syndrome	0.000206	0.00427	CbGpPWpGaD
Entacapone—COMT—Neuronal System—GLUL—epilepsy syndrome	0.000204	0.00423	CbGpPWpGaD
Entacapone—COMT—Neuronal System—GRIA2—epilepsy syndrome	0.0002	0.00416	CbGpPWpGaD
Entacapone—COMT—Transmission across Chemical Synapses—GABBR1—epilepsy syndrome	0.000196	0.00407	CbGpPWpGaD
Entacapone—COMT—Neuronal System—SLC1A2—epilepsy syndrome	0.000193	0.00401	CbGpPWpGaD
Entacapone—COMT—Neuronal System—CHRNA7—epilepsy syndrome	0.000193	0.00401	CbGpPWpGaD
Entacapone—COMT—Neuronal System—GRIK1—epilepsy syndrome	0.000193	0.00401	CbGpPWpGaD
Entacapone—COMT—Biological oxidations—CYP2C19—epilepsy syndrome	0.000192	0.00399	CbGpPWpGaD
Entacapone—COMT—Transmission across Chemical Synapses—SLC6A1—epilepsy syndrome	0.000191	0.00397	CbGpPWpGaD
Entacapone—COMT—Transmission across Chemical Synapses—GRIN2A—epilepsy syndrome	0.000191	0.00397	CbGpPWpGaD
Entacapone—COMT—Transmission across Chemical Synapses—GRIA1—epilepsy syndrome	0.000191	0.00397	CbGpPWpGaD
Entacapone—COMT—Biological oxidations—CYP11A1—epilepsy syndrome	0.000191	0.00397	CbGpPWpGaD
Entacapone—COMT—Metapathway biotransformation—CYP2C19—epilepsy syndrome	0.00019	0.00394	CbGpPWpGaD
Entacapone—COMT—Metapathway biotransformation—CYP11A1—epilepsy syndrome	0.000189	0.00391	CbGpPWpGaD
Entacapone—UGT1A9—NRF2 pathway—TXNRD1—epilepsy syndrome	0.000188	0.00391	CbGpPWpGaD
Entacapone—COMT—Neuronal System—GABRB2—epilepsy syndrome	0.000185	0.00383	CbGpPWpGaD
Entacapone—COMT—Neuronal System—GAD2—epilepsy syndrome	0.000182	0.00377	CbGpPWpGaD
Entacapone—COMT—Transmission across Chemical Synapses—CHRNB2—epilepsy syndrome	0.000181	0.00376	CbGpPWpGaD
Entacapone—COMT—Biological oxidations—CYP2D6—epilepsy syndrome	0.000173	0.00358	CbGpPWpGaD
Entacapone—COMT—Neuronal System—KCNMA1—epilepsy syndrome	0.000172	0.00358	CbGpPWpGaD
Entacapone—COMT—Metapathway biotransformation—CYP2D6—epilepsy syndrome	0.00017	0.00353	CbGpPWpGaD
Entacapone—COMT—Transmission across Chemical Synapses—CHRNA4—epilepsy syndrome	0.000165	0.00341	CbGpPWpGaD
Entacapone—COMT—Neuronal System—KCNJ11—epilepsy syndrome	0.000165	0.00341	CbGpPWpGaD
Entacapone—COMT—Neuronal System—GRIK2—epilepsy syndrome	0.000165	0.00341	CbGpPWpGaD
Entacapone—COMT—Neuronal System—SLC1A3—epilepsy syndrome	0.000165	0.00341	CbGpPWpGaD
Entacapone—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—TXNRD1—epilepsy syndrome	0.000159	0.00331	CbGpPWpGaD
Entacapone—UGT1A9—NRF2 pathway—ABCC2—epilepsy syndrome	0.000159	0.00329	CbGpPWpGaD
Entacapone—COMT—Neuronal System—GAD1—epilepsy syndrome	0.000158	0.00327	CbGpPWpGaD
Entacapone—COMT—Neuronal System—GABBR1—epilepsy syndrome	0.00015	0.00312	CbGpPWpGaD
Entacapone—UGT1A9—NRF2 pathway—SLC6A1—epilepsy syndrome	0.000147	0.00306	CbGpPWpGaD
Entacapone—COMT—Neuronal System—SLC6A1—epilepsy syndrome	0.000147	0.00304	CbGpPWpGaD
Entacapone—COMT—Neuronal System—GRIA1—epilepsy syndrome	0.000147	0.00304	CbGpPWpGaD
Entacapone—COMT—Neuronal System—GRIN2A—epilepsy syndrome	0.000147	0.00304	CbGpPWpGaD
Entacapone—COMT—Transmission across Chemical Synapses—BCHE—epilepsy syndrome	0.000145	0.00301	CbGpPWpGaD
Entacapone—COMT—Transmission across Chemical Synapses—DLG4—epilepsy syndrome	0.000142	0.00294	CbGpPWpGaD
Entacapone—COMT—Neuronal System—CHRNB2—epilepsy syndrome	0.000139	0.00288	CbGpPWpGaD
Entacapone—COMT—Transmission across Chemical Synapses—GRIN2B—epilepsy syndrome	0.000138	0.00287	CbGpPWpGaD
Entacapone—COMT—Transmission across Chemical Synapses—PLCB1—epilepsy syndrome	0.000137	0.00284	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—CERS1—epilepsy syndrome	0.000134	0.00278	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—FAR1—epilepsy syndrome	0.000134	0.00278	CbGpPWpGaD
Entacapone—COMT—Metabolism—CA13—epilepsy syndrome	0.000132	0.00273	CbGpPWpGaD
Entacapone—COMT—Neuronal System—CHRNA4—epilepsy syndrome	0.000126	0.00262	CbGpPWpGaD
Entacapone—UGT1A9—NRF2 pathway—SLC6A4—epilepsy syndrome	0.000118	0.00245	CbGpPWpGaD
Entacapone—UGT1A9—Biological oxidations—CYP2C19—epilepsy syndrome	0.000115	0.00239	CbGpPWpGaD
Entacapone—UGT1A9—Biological oxidations—CYP11A1—epilepsy syndrome	0.000115	0.00238	CbGpPWpGaD
Entacapone—UGT1A9—Metapathway biotransformation—CYP2C19—epilepsy syndrome	0.000114	0.00236	CbGpPWpGaD
Entacapone—UGT1A9—Metapathway biotransformation—CYP11A1—epilepsy syndrome	0.000113	0.00234	CbGpPWpGaD
Entacapone—COMT—Neuronal System—BCHE—epilepsy syndrome	0.000111	0.00231	CbGpPWpGaD
Entacapone—COMT—Neuronal System—DLG4—epilepsy syndrome	0.000108	0.00225	CbGpPWpGaD
Entacapone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL1B—epilepsy syndrome	0.000108	0.00224	CbGpPWpGaD
Entacapone—UGT1A9—NRF2 pathway—SLC2A1—epilepsy syndrome	0.000107	0.00221	CbGpPWpGaD
Entacapone—COMT—Neuronal System—GRIN2B—epilepsy syndrome	0.000106	0.0022	CbGpPWpGaD
Entacapone—COMT—Neuronal System—PLCB1—epilepsy syndrome	0.000105	0.00218	CbGpPWpGaD
Entacapone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—JUN—epilepsy syndrome	0.000105	0.00217	CbGpPWpGaD
Entacapone—UGT1A9—Biological oxidations—CYP2D6—epilepsy syndrome	0.000103	0.00215	CbGpPWpGaD
Entacapone—UGT1A9—Metapathway biotransformation—CYP2D6—epilepsy syndrome	0.000102	0.00212	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—SLCO1A2—epilepsy syndrome	0.000102	0.00211	CbGpPWpGaD
Entacapone—UGT1A9—NRF2 pathway—HBEGF—epilepsy syndrome	0.0001	0.00208	CbGpPWpGaD
Entacapone—COMT—Metabolism—FAR1—epilepsy syndrome	9.98e-05	0.00207	CbGpPWpGaD
Entacapone—COMT—Metabolism—ADK—epilepsy syndrome	9.98e-05	0.00207	CbGpPWpGaD
Entacapone—COMT—Metabolism—L2HGDH—epilepsy syndrome	9.98e-05	0.00207	CbGpPWpGaD
Entacapone—COMT—Metabolism—GLUD1—epilepsy syndrome	9.98e-05	0.00207	CbGpPWpGaD
Entacapone—COMT—Metabolism—CERS1—epilepsy syndrome	9.98e-05	0.00207	CbGpPWpGaD
Entacapone—COMT—Metabolism—PDXK—epilepsy syndrome	9.98e-05	0.00207	CbGpPWpGaD
Entacapone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—SRC—epilepsy syndrome	9.39e-05	0.00195	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—NEU1—epilepsy syndrome	9.3e-05	0.00193	CbGpPWpGaD
Entacapone—COMT—Metabolism—GAMT—epilepsy syndrome	9.12e-05	0.00189	CbGpPWpGaD
Entacapone—COMT—Metabolism—PNPO—epilepsy syndrome	9.12e-05	0.00189	CbGpPWpGaD
Entacapone—COMT—Metabolism—EPM2A—epilepsy syndrome	9.12e-05	0.00189	CbGpPWpGaD
Entacapone—COMT—Metabolism—NHLRC1—epilepsy syndrome	9.12e-05	0.00189	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—HSD17B4—epilepsy syndrome	8.95e-05	0.00186	CbGpPWpGaD
Entacapone—UGT1A9—NRF2 pathway—HMOX1—epilepsy syndrome	8.77e-05	0.00182	CbGpPWpGaD
Entacapone—UGT1A9—PPARA activates gene expression—AGT—epilepsy syndrome	8.61e-05	0.00179	CbGpPWpGaD
Entacapone—COMT—Metabolism—QDPR—epilepsy syndrome	8.48e-05	0.00176	CbGpPWpGaD
Entacapone—COMT—Metabolism—CA4—epilepsy syndrome	8.48e-05	0.00176	CbGpPWpGaD
Entacapone—COMT—Biological oxidations—POMC—epilepsy syndrome	8.46e-05	0.00175	CbGpPWpGaD
Entacapone—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—AGT—epilepsy syndrome	8.42e-05	0.00175	CbGpPWpGaD
Entacapone—COMT—Transmission across Chemical Synapses—PRKCB—epilepsy syndrome	8.23e-05	0.00171	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—ASAH1—epilepsy syndrome	8.13e-05	0.00169	CbGpPWpGaD
Entacapone—COMT—Metabolism—COX3—epilepsy syndrome	7.98e-05	0.00165	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—CA13—epilepsy syndrome	7.89e-05	0.00164	CbGpPWpGaD
Entacapone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TNF—epilepsy syndrome	7.83e-05	0.00163	CbGpPWpGaD
Entacapone—COMT—Metabolism—PFKL—epilepsy syndrome	7.56e-05	0.00157	CbGpPWpGaD
Entacapone—COMT—Metabolism—KCNB1—epilepsy syndrome	7.56e-05	0.00157	CbGpPWpGaD
Entacapone—COMT—Metabolism—SLCO1A2—epilepsy syndrome	7.56e-05	0.00157	CbGpPWpGaD
Entacapone—COMT—Metabolism—CACNA2D2—epilepsy syndrome	7.56e-05	0.00157	CbGpPWpGaD
Entacapone—COMT—Metabolism—SLC6A8—epilepsy syndrome	7.56e-05	0.00157	CbGpPWpGaD
Entacapone—COMT—Metabolism—ATIC—epilepsy syndrome	6.91e-05	0.00143	CbGpPWpGaD
Entacapone—COMT—Metabolism—UPB1—epilepsy syndrome	6.91e-05	0.00143	CbGpPWpGaD
Entacapone—COMT—Metabolism—NEU1—epilepsy syndrome	6.91e-05	0.00143	CbGpPWpGaD
Entacapone—COMT—Metabolism—HSD17B4—epilepsy syndrome	6.66e-05	0.00138	CbGpPWpGaD
Entacapone—COMT—Metabolism—GBE1—epilepsy syndrome	6.43e-05	0.00133	CbGpPWpGaD
Entacapone—COMT—Metabolism—PPP1R3C—epilepsy syndrome	6.43e-05	0.00133	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	6.35e-05	0.00132	CbGpPWpGaD
Entacapone—COMT—Neuronal System—PRKCB—epilepsy syndrome	6.3e-05	0.00131	CbGpPWpGaD
Entacapone—COMT—Metabolism—ASAH1—epilepsy syndrome	6.04e-05	0.00125	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—CERS1—epilepsy syndrome	5.98e-05	0.00124	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—L2HGDH—epilepsy syndrome	5.98e-05	0.00124	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—PDXK—epilepsy syndrome	5.98e-05	0.00124	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—FAR1—epilepsy syndrome	5.98e-05	0.00124	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—GLUD1—epilepsy syndrome	5.98e-05	0.00124	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—ADK—epilepsy syndrome	5.98e-05	0.00124	CbGpPWpGaD
Entacapone—COMT—Metabolism—STXBP1—epilepsy syndrome	5.88e-05	0.00122	CbGpPWpGaD
Entacapone—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—epilepsy syndrome	5.8e-05	0.0012	CbGpPWpGaD
Entacapone—COMT—Metabolism—NT5E—epilepsy syndrome	5.73e-05	0.00119	CbGpPWpGaD
Entacapone—COMT—Metabolism—ALAD—epilepsy syndrome	5.73e-05	0.00119	CbGpPWpGaD
Entacapone—COMT—Metabolism—ALDH7A1—epilepsy syndrome	5.47e-05	0.00113	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—PNPO—epilepsy syndrome	5.47e-05	0.00113	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—EPM2A—epilepsy syndrome	5.47e-05	0.00113	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—NHLRC1—epilepsy syndrome	5.47e-05	0.00113	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—GAMT—epilepsy syndrome	5.47e-05	0.00113	CbGpPWpGaD
Entacapone—COMT—Metabolism—CACNA1A—epilepsy syndrome	5.47e-05	0.00113	CbGpPWpGaD
Entacapone—COMT—Metabolism—ST3GAL3—epilepsy syndrome	5.35e-05	0.00111	CbGpPWpGaD
Entacapone—COMT—Metabolism—ADSL—epilepsy syndrome	5.24e-05	0.00109	CbGpPWpGaD
Entacapone—COMT—Metabolism—GLUL—epilepsy syndrome	5.14e-05	0.00107	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—QDPR—epilepsy syndrome	5.08e-05	0.00105	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—CA4—epilepsy syndrome	5.08e-05	0.00105	CbGpPWpGaD
Entacapone—UGT1A9—Biological oxidations—POMC—epilepsy syndrome	5.07e-05	0.00105	CbGpPWpGaD
Entacapone—COMT—Metabolism—CACNA1D—epilepsy syndrome	5.04e-05	0.00105	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—COX3—epilepsy syndrome	4.78e-05	0.000991	CbGpPWpGaD
Entacapone—COMT—Metabolism—TXNRD1—epilepsy syndrome	4.72e-05	0.000979	CbGpPWpGaD
Entacapone—COMT—Metabolism—AQP1—epilepsy syndrome	4.58e-05	0.00095	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—CACNA2D2—epilepsy syndrome	4.53e-05	0.00094	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—KCNB1—epilepsy syndrome	4.53e-05	0.00094	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—PFKL—epilepsy syndrome	4.53e-05	0.00094	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—SLCO1A2—epilepsy syndrome	4.53e-05	0.00094	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—SLC6A8—epilepsy syndrome	4.53e-05	0.00094	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	4.43e-05	0.000918	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	4.4e-05	0.000913	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—UPB1—epilepsy syndrome	4.14e-05	0.00086	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—NEU1—epilepsy syndrome	4.14e-05	0.00086	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—ATIC—epilepsy syndrome	4.14e-05	0.00086	CbGpPWpGaD
Entacapone—COMT—Metabolism—CHRM3—epilepsy syndrome	4.14e-05	0.00086	CbGpPWpGaD
Entacapone—COMT—Metabolism—KCNJ11—epilepsy syndrome	4.14e-05	0.00086	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—HSD17B4—epilepsy syndrome	3.99e-05	0.000827	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—GBE1—epilepsy syndrome	3.85e-05	0.000799	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—PPP1R3C—epilepsy syndrome	3.85e-05	0.000799	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	3.76e-05	0.000781	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—ASAH1—epilepsy syndrome	3.62e-05	0.000751	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—STXBP1—epilepsy syndrome	3.52e-05	0.000731	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—NT5E—epilepsy syndrome	3.43e-05	0.000712	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—ALAD—epilepsy syndrome	3.43e-05	0.000712	CbGpPWpGaD
Entacapone—COMT—Metabolism—ABCG2—epilepsy syndrome	3.38e-05	0.000701	CbGpPWpGaD
Entacapone—Headache—Vigabatrin—epilepsy syndrome	3.33e-05	0.000161	CcSEcCtD
Entacapone—Hypertension—Pregabalin—epilepsy syndrome	3.32e-05	0.000161	CcSEcCtD
Entacapone—Vomiting—Diazepam—epilepsy syndrome	3.32e-05	0.000161	CcSEcCtD
Entacapone—Anorexia—Valproic Acid—epilepsy syndrome	3.31e-05	0.00016	CcSEcCtD
Entacapone—Tremor—Gabapentin—epilepsy syndrome	3.31e-05	0.00016	CcSEcCtD
Entacapone—Rash—Diazepam—epilepsy syndrome	3.3e-05	0.00016	CcSEcCtD
Entacapone—Dermatitis—Diazepam—epilepsy syndrome	3.29e-05	0.000159	CcSEcCtD
Entacapone—COMT—Metabolism—CYP2C19—epilepsy syndrome	3.29e-05	0.000683	CbGpPWpGaD
Entacapone—Visual impairment—Topiramate—epilepsy syndrome	3.29e-05	0.000159	CcSEcCtD
Entacapone—Myalgia—Pregabalin—epilepsy syndrome	3.28e-05	0.000159	CcSEcCtD
Entacapone—Chest pain—Pregabalin—epilepsy syndrome	3.28e-05	0.000159	CcSEcCtD
Entacapone—Ill-defined disorder—Gabapentin—epilepsy syndrome	3.28e-05	0.000159	CcSEcCtD
Entacapone—Dizziness—Zonisamide—epilepsy syndrome	3.28e-05	0.000158	CcSEcCtD
Entacapone—Headache—Diazepam—epilepsy syndrome	3.28e-05	0.000158	CcSEcCtD
Entacapone—UGT1A9—Metabolism—CACNA1A—epilepsy syndrome	3.27e-05	0.000679	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—ALDH7A1—epilepsy syndrome	3.27e-05	0.000679	CbGpPWpGaD
Entacapone—COMT—Metabolism—CYP11A1—epilepsy syndrome	3.27e-05	0.000679	CbGpPWpGaD
Entacapone—Anxiety—Pregabalin—epilepsy syndrome	3.27e-05	0.000158	CcSEcCtD
Entacapone—Diarrhoea—Clonazepam—epilepsy syndrome	3.27e-05	0.000158	CcSEcCtD
Entacapone—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	3.26e-05	0.000158	CcSEcCtD
Entacapone—Hypotension—Valproic Acid—epilepsy syndrome	3.25e-05	0.000157	CcSEcCtD
Entacapone—Asthenia—Carbamazepine—epilepsy syndrome	3.25e-05	0.000157	CcSEcCtD
Entacapone—Agitation—Gabapentin—epilepsy syndrome	3.24e-05	0.000157	CcSEcCtD
Entacapone—Diarrhoea—Phenytoin—epilepsy syndrome	3.24e-05	0.000157	CcSEcCtD
Entacapone—Discomfort—Pregabalin—epilepsy syndrome	3.24e-05	0.000157	CcSEcCtD
Entacapone—Nausea—Fosphenytoin—epilepsy syndrome	3.24e-05	0.000157	CcSEcCtD
Entacapone—Diarrhoea—Oxcarbazepine—epilepsy syndrome	3.23e-05	0.000156	CcSEcCtD
Entacapone—Erythema multiforme—Topiramate—epilepsy syndrome	3.23e-05	0.000156	CcSEcCtD
Entacapone—Angioedema—Gabapentin—epilepsy syndrome	3.23e-05	0.000156	CcSEcCtD
Entacapone—Hypersensitivity—Lamotrigine—epilepsy syndrome	3.22e-05	0.000156	CcSEcCtD
Entacapone—Vomiting—Felbamate—epilepsy syndrome	3.22e-05	0.000156	CcSEcCtD
Entacapone—Dry mouth—Pregabalin—epilepsy syndrome	3.21e-05	0.000155	CcSEcCtD
Entacapone—UGT1A9—Metabolism—ST3GAL3—epilepsy syndrome	3.2e-05	0.000665	CbGpPWpGaD
Entacapone—Pruritus—Carbamazepine—epilepsy syndrome	3.2e-05	0.000155	CcSEcCtD
Entacapone—Rash—Felbamate—epilepsy syndrome	3.19e-05	0.000154	CcSEcCtD
Entacapone—Eye disorder—Topiramate—epilepsy syndrome	3.19e-05	0.000154	CcSEcCtD
Entacapone—Dermatitis—Felbamate—epilepsy syndrome	3.19e-05	0.000154	CcSEcCtD
Entacapone—Malaise—Gabapentin—epilepsy syndrome	3.18e-05	0.000154	CcSEcCtD
Entacapone—Vertigo—Gabapentin—epilepsy syndrome	3.17e-05	0.000153	CcSEcCtD
Entacapone—Headache—Felbamate—epilepsy syndrome	3.17e-05	0.000153	CcSEcCtD
Entacapone—Confusional state—Pregabalin—epilepsy syndrome	3.17e-05	0.000153	CcSEcCtD
Entacapone—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	3.17e-05	0.000153	CcSEcCtD
Entacapone—Cardiac disorder—Topiramate—epilepsy syndrome	3.17e-05	0.000153	CcSEcCtD
Entacapone—Flushing—Topiramate—epilepsy syndrome	3.17e-05	0.000153	CcSEcCtD
Entacapone—Syncope—Gabapentin—epilepsy syndrome	3.17e-05	0.000153	CcSEcCtD
Entacapone—Leukopenia—Gabapentin—epilepsy syndrome	3.16e-05	0.000153	CcSEcCtD
Entacapone—Dizziness—Clonazepam—epilepsy syndrome	3.16e-05	0.000153	CcSEcCtD
Entacapone—Nausea—Vigabatrin—epilepsy syndrome	3.15e-05	0.000153	CcSEcCtD
Entacapone—Vomiting—Zonisamide—epilepsy syndrome	3.15e-05	0.000152	CcSEcCtD
Entacapone—Insomnia—Valproic Acid—epilepsy syndrome	3.14e-05	0.000152	CcSEcCtD
Entacapone—Oedema—Pregabalin—epilepsy syndrome	3.14e-05	0.000152	CcSEcCtD
Entacapone—UGT1A9—Metabolism—ADSL—epilepsy syndrome	3.14e-05	0.000651	CbGpPWpGaD
Entacapone—Asthenia—Lamotrigine—epilepsy syndrome	3.14e-05	0.000152	CcSEcCtD
Entacapone—Dizziness—Phenytoin—epilepsy syndrome	3.14e-05	0.000152	CcSEcCtD
Entacapone—Rash—Zonisamide—epilepsy syndrome	3.12e-05	0.000151	CcSEcCtD
Entacapone—Paraesthesia—Valproic Acid—epilepsy syndrome	3.12e-05	0.000151	CcSEcCtD
Entacapone—Palpitations—Gabapentin—epilepsy syndrome	3.12e-05	0.000151	CcSEcCtD
Entacapone—Dermatitis—Zonisamide—epilepsy syndrome	3.12e-05	0.000151	CcSEcCtD
Entacapone—Dizziness—Oxcarbazepine—epilepsy syndrome	3.12e-05	0.000151	CcSEcCtD
Entacapone—Nausea—Diazepam—epilepsy syndrome	3.11e-05	0.00015	CcSEcCtD
Entacapone—Loss of consciousness—Gabapentin—epilepsy syndrome	3.1e-05	0.00015	CcSEcCtD
Entacapone—Headache—Zonisamide—epilepsy syndrome	3.1e-05	0.00015	CcSEcCtD
Entacapone—Dyspnoea—Valproic Acid—epilepsy syndrome	3.1e-05	0.00015	CcSEcCtD
Entacapone—Diarrhoea—Carbamazepine—epilepsy syndrome	3.1e-05	0.00015	CcSEcCtD
Entacapone—Pruritus—Lamotrigine—epilepsy syndrome	3.09e-05	0.00015	CcSEcCtD
Entacapone—Shock—Pregabalin—epilepsy syndrome	3.09e-05	0.00015	CcSEcCtD
Entacapone—Somnolence—Valproic Acid—epilepsy syndrome	3.09e-05	0.00015	CcSEcCtD
Entacapone—Nervous system disorder—Pregabalin—epilepsy syndrome	3.08e-05	0.000149	CcSEcCtD
Entacapone—Cough—Gabapentin—epilepsy syndrome	3.08e-05	0.000149	CcSEcCtD
Entacapone—UGT1A9—Metabolism—GLUL—epilepsy syndrome	3.08e-05	0.000639	CbGpPWpGaD
Entacapone—Thrombocytopenia—Pregabalin—epilepsy syndrome	3.08e-05	0.000149	CcSEcCtD
Entacapone—Dyspepsia—Valproic Acid—epilepsy syndrome	3.06e-05	0.000148	CcSEcCtD
Entacapone—Convulsion—Gabapentin—epilepsy syndrome	3.06e-05	0.000148	CcSEcCtD
Entacapone—Skin disorder—Pregabalin—epilepsy syndrome	3.05e-05	0.000148	CcSEcCtD
Entacapone—Hypertension—Gabapentin—epilepsy syndrome	3.05e-05	0.000148	CcSEcCtD
Entacapone—Hyperhidrosis—Pregabalin—epilepsy syndrome	3.04e-05	0.000147	CcSEcCtD
Entacapone—Vomiting—Clonazepam—epilepsy syndrome	3.04e-05	0.000147	CcSEcCtD
Entacapone—UGT1A9—Metabolism—CACNA1D—epilepsy syndrome	3.02e-05	0.000627	CbGpPWpGaD
Entacapone—Decreased appetite—Valproic Acid—epilepsy syndrome	3.02e-05	0.000146	CcSEcCtD
Entacapone—Alopecia—Topiramate—epilepsy syndrome	3.02e-05	0.000146	CcSEcCtD
Entacapone—Vomiting—Phenytoin—epilepsy syndrome	3.01e-05	0.000146	CcSEcCtD
Entacapone—Rash—Clonazepam—epilepsy syndrome	3.01e-05	0.000146	CcSEcCtD
Entacapone—Dermatitis—Clonazepam—epilepsy syndrome	3.01e-05	0.000146	CcSEcCtD
Entacapone—Chest pain—Gabapentin—epilepsy syndrome	3.01e-05	0.000145	CcSEcCtD
Entacapone—Myalgia—Gabapentin—epilepsy syndrome	3.01e-05	0.000145	CcSEcCtD
Entacapone—Nausea—Felbamate—epilepsy syndrome	3.01e-05	0.000145	CcSEcCtD
Entacapone—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	3e-05	0.000145	CcSEcCtD
Entacapone—Vomiting—Oxcarbazepine—epilepsy syndrome	3e-05	0.000145	CcSEcCtD
Entacapone—Fatigue—Valproic Acid—epilepsy syndrome	3e-05	0.000145	CcSEcCtD
Entacapone—Anxiety—Gabapentin—epilepsy syndrome	3e-05	0.000145	CcSEcCtD
Entacapone—Anorexia—Pregabalin—epilepsy syndrome	3e-05	0.000145	CcSEcCtD
Entacapone—Dizziness—Carbamazepine—epilepsy syndrome	2.99e-05	0.000145	CcSEcCtD
Entacapone—Diarrhoea—Lamotrigine—epilepsy syndrome	2.99e-05	0.000145	CcSEcCtD
Entacapone—Headache—Clonazepam—epilepsy syndrome	2.99e-05	0.000145	CcSEcCtD
Entacapone—Rash—Phenytoin—epilepsy syndrome	2.99e-05	0.000145	CcSEcCtD
Entacapone—Mental disorder—Topiramate—epilepsy syndrome	2.99e-05	0.000145	CcSEcCtD
Entacapone—Dermatitis—Phenytoin—epilepsy syndrome	2.99e-05	0.000145	CcSEcCtD
Entacapone—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	2.99e-05	0.000144	CcSEcCtD
Entacapone—Rash—Oxcarbazepine—epilepsy syndrome	2.97e-05	0.000144	CcSEcCtD
Entacapone—Constipation—Valproic Acid—epilepsy syndrome	2.97e-05	0.000144	CcSEcCtD
Entacapone—Pain—Valproic Acid—epilepsy syndrome	2.97e-05	0.000144	CcSEcCtD
Entacapone—Dermatitis—Oxcarbazepine—epilepsy syndrome	2.97e-05	0.000144	CcSEcCtD
Entacapone—Headache—Phenytoin—epilepsy syndrome	2.97e-05	0.000144	CcSEcCtD
Entacapone—Malnutrition—Topiramate—epilepsy syndrome	2.97e-05	0.000144	CcSEcCtD
Entacapone—Discomfort—Gabapentin—epilepsy syndrome	2.97e-05	0.000144	CcSEcCtD
Entacapone—Headache—Oxcarbazepine—epilepsy syndrome	2.95e-05	0.000143	CcSEcCtD
Entacapone—COMT—Metabolism—CYP2D6—epilepsy syndrome	2.95e-05	0.000612	CbGpPWpGaD
Entacapone—Nausea—Zonisamide—epilepsy syndrome	2.94e-05	0.000142	CcSEcCtD
Entacapone—Dry mouth—Gabapentin—epilepsy syndrome	2.94e-05	0.000142	CcSEcCtD
Entacapone—Hypotension—Pregabalin—epilepsy syndrome	2.94e-05	0.000142	CcSEcCtD
Entacapone—Flatulence—Topiramate—epilepsy syndrome	2.93e-05	0.000142	CcSEcCtD
Entacapone—Tension—Topiramate—epilepsy syndrome	2.91e-05	0.000141	CcSEcCtD
Entacapone—Dysgeusia—Topiramate—epilepsy syndrome	2.91e-05	0.000141	CcSEcCtD
Entacapone—Confusional state—Gabapentin—epilepsy syndrome	2.91e-05	0.000141	CcSEcCtD
Entacapone—Dizziness—Lamotrigine—epilepsy syndrome	2.89e-05	0.00014	CcSEcCtD
Entacapone—Nervousness—Topiramate—epilepsy syndrome	2.88e-05	0.00014	CcSEcCtD
Entacapone—Oedema—Gabapentin—epilepsy syndrome	2.88e-05	0.000139	CcSEcCtD
Entacapone—Vomiting—Carbamazepine—epilepsy syndrome	2.88e-05	0.000139	CcSEcCtD
Entacapone—Back pain—Topiramate—epilepsy syndrome	2.87e-05	0.000139	CcSEcCtD
Entacapone—Feeling abnormal—Valproic Acid—epilepsy syndrome	2.86e-05	0.000139	CcSEcCtD
Entacapone—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	2.86e-05	0.000139	CcSEcCtD
Entacapone—Muscle spasms—Topiramate—epilepsy syndrome	2.86e-05	0.000138	CcSEcCtD
Entacapone—Rash—Carbamazepine—epilepsy syndrome	2.85e-05	0.000138	CcSEcCtD
Entacapone—Dermatitis—Carbamazepine—epilepsy syndrome	2.85e-05	0.000138	CcSEcCtD
Entacapone—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	2.84e-05	0.000138	CcSEcCtD
Entacapone—Insomnia—Pregabalin—epilepsy syndrome	2.84e-05	0.000138	CcSEcCtD
Entacapone—Nausea—Clonazepam—epilepsy syndrome	2.84e-05	0.000137	CcSEcCtD
Entacapone—Headache—Carbamazepine—epilepsy syndrome	2.84e-05	0.000137	CcSEcCtD
Entacapone—Shock—Gabapentin—epilepsy syndrome	2.83e-05	0.000137	CcSEcCtD
Entacapone—UGT1A9—Metabolism—TXNRD1—epilepsy syndrome	2.83e-05	0.000586	CbGpPWpGaD
Entacapone—Nervous system disorder—Gabapentin—epilepsy syndrome	2.83e-05	0.000137	CcSEcCtD
Entacapone—Paraesthesia—Pregabalin—epilepsy syndrome	2.82e-05	0.000137	CcSEcCtD
Entacapone—Thrombocytopenia—Gabapentin—epilepsy syndrome	2.82e-05	0.000137	CcSEcCtD
Entacapone—Nausea—Phenytoin—epilepsy syndrome	2.82e-05	0.000136	CcSEcCtD
Entacapone—COMT—Metabolism—ADRA2A—epilepsy syndrome	2.81e-05	0.000583	CbGpPWpGaD
Entacapone—Dyspnoea—Pregabalin—epilepsy syndrome	2.8e-05	0.000136	CcSEcCtD
Entacapone—Nausea—Oxcarbazepine—epilepsy syndrome	2.8e-05	0.000136	CcSEcCtD
Entacapone—Vision blurred—Topiramate—epilepsy syndrome	2.8e-05	0.000135	CcSEcCtD
Entacapone—Skin disorder—Gabapentin—epilepsy syndrome	2.8e-05	0.000135	CcSEcCtD
Entacapone—COMT—Metabolism—BCHE—epilepsy syndrome	2.8e-05	0.000581	CbGpPWpGaD
Entacapone—Somnolence—Pregabalin—epilepsy syndrome	2.79e-05	0.000135	CcSEcCtD
Entacapone—Hyperhidrosis—Gabapentin—epilepsy syndrome	2.79e-05	0.000135	CcSEcCtD
Entacapone—Tremor—Topiramate—epilepsy syndrome	2.78e-05	0.000135	CcSEcCtD
Entacapone—Vomiting—Lamotrigine—epilepsy syndrome	2.78e-05	0.000135	CcSEcCtD
Entacapone—Urticaria—Valproic Acid—epilepsy syndrome	2.76e-05	0.000134	CcSEcCtD
Entacapone—Rash—Lamotrigine—epilepsy syndrome	2.76e-05	0.000133	CcSEcCtD
Entacapone—Ill-defined disorder—Topiramate—epilepsy syndrome	2.76e-05	0.000133	CcSEcCtD
Entacapone—Dermatitis—Lamotrigine—epilepsy syndrome	2.76e-05	0.000133	CcSEcCtD
Entacapone—Body temperature increased—Valproic Acid—epilepsy syndrome	2.75e-05	0.000133	CcSEcCtD
Entacapone—Abdominal pain—Valproic Acid—epilepsy syndrome	2.75e-05	0.000133	CcSEcCtD
Entacapone—Anorexia—Gabapentin—epilepsy syndrome	2.75e-05	0.000133	CcSEcCtD
Entacapone—UGT1A9—Metabolism—AQP1—epilepsy syndrome	2.74e-05	0.000569	CbGpPWpGaD
Entacapone—Headache—Lamotrigine—epilepsy syndrome	2.74e-05	0.000133	CcSEcCtD
Entacapone—Decreased appetite—Pregabalin—epilepsy syndrome	2.73e-05	0.000132	CcSEcCtD
Entacapone—Agitation—Topiramate—epilepsy syndrome	2.73e-05	0.000132	CcSEcCtD
Entacapone—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	2.71e-05	0.000131	CcSEcCtD
Entacapone—Fatigue—Pregabalin—epilepsy syndrome	2.71e-05	0.000131	CcSEcCtD
Entacapone—Hypotension—Gabapentin—epilepsy syndrome	2.69e-05	0.00013	CcSEcCtD
Entacapone—Nausea—Carbamazepine—epilepsy syndrome	2.69e-05	0.00013	CcSEcCtD
Entacapone—Constipation—Pregabalin—epilepsy syndrome	2.69e-05	0.00013	CcSEcCtD
Entacapone—Pain—Pregabalin—epilepsy syndrome	2.69e-05	0.00013	CcSEcCtD
Entacapone—Malaise—Topiramate—epilepsy syndrome	2.68e-05	0.00013	CcSEcCtD
Entacapone—COMT—Metabolism—SLC2A1—epilepsy syndrome	2.67e-05	0.000554	CbGpPWpGaD
Entacapone—Vertigo—Topiramate—epilepsy syndrome	2.67e-05	0.000129	CcSEcCtD
Entacapone—Syncope—Topiramate—epilepsy syndrome	2.66e-05	0.000129	CcSEcCtD
Entacapone—Leukopenia—Topiramate—epilepsy syndrome	2.66e-05	0.000129	CcSEcCtD
Entacapone—COMT—Metabolism—PLCB1—epilepsy syndrome	2.64e-05	0.000548	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	2.64e-05	0.000547	CbGpPWpGaD
Entacapone—COMT—Metabolism—TH—epilepsy syndrome	2.63e-05	0.000546	CbGpPWpGaD
Entacapone—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	2.63e-05	0.000127	CcSEcCtD
Entacapone—Palpitations—Topiramate—epilepsy syndrome	2.62e-05	0.000127	CcSEcCtD
Entacapone—Loss of consciousness—Topiramate—epilepsy syndrome	2.61e-05	0.000126	CcSEcCtD
Entacapone—Insomnia—Gabapentin—epilepsy syndrome	2.61e-05	0.000126	CcSEcCtD
Entacapone—Nausea—Lamotrigine—epilepsy syndrome	2.6e-05	0.000126	CcSEcCtD
Entacapone—Cough—Topiramate—epilepsy syndrome	2.59e-05	0.000125	CcSEcCtD
Entacapone—Feeling abnormal—Pregabalin—epilepsy syndrome	2.59e-05	0.000125	CcSEcCtD
Entacapone—Paraesthesia—Gabapentin—epilepsy syndrome	2.59e-05	0.000125	CcSEcCtD
Entacapone—Convulsion—Topiramate—epilepsy syndrome	2.57e-05	0.000125	CcSEcCtD
Entacapone—Gastrointestinal pain—Pregabalin—epilepsy syndrome	2.57e-05	0.000124	CcSEcCtD
Entacapone—Dyspnoea—Gabapentin—epilepsy syndrome	2.57e-05	0.000124	CcSEcCtD
Entacapone—Hypertension—Topiramate—epilepsy syndrome	2.56e-05	0.000124	CcSEcCtD
Entacapone—Somnolence—Gabapentin—epilepsy syndrome	2.56e-05	0.000124	CcSEcCtD
Entacapone—Hypersensitivity—Valproic Acid—epilepsy syndrome	2.56e-05	0.000124	CcSEcCtD
Entacapone—Dyspepsia—Gabapentin—epilepsy syndrome	2.54e-05	0.000123	CcSEcCtD
Entacapone—Myalgia—Topiramate—epilepsy syndrome	2.53e-05	0.000122	CcSEcCtD
Entacapone—Chest pain—Topiramate—epilepsy syndrome	2.53e-05	0.000122	CcSEcCtD
Entacapone—Anxiety—Topiramate—epilepsy syndrome	2.52e-05	0.000122	CcSEcCtD
Entacapone—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	2.51e-05	0.000122	CcSEcCtD
Entacapone—Decreased appetite—Gabapentin—epilepsy syndrome	2.5e-05	0.000121	CcSEcCtD
Entacapone—Discomfort—Topiramate—epilepsy syndrome	2.5e-05	0.000121	CcSEcCtD
Entacapone—Urticaria—Pregabalin—epilepsy syndrome	2.5e-05	0.000121	CcSEcCtD
Entacapone—Asthenia—Valproic Acid—epilepsy syndrome	2.49e-05	0.000121	CcSEcCtD
Entacapone—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	2.49e-05	0.00012	CcSEcCtD
Entacapone—Fatigue—Gabapentin—epilepsy syndrome	2.48e-05	0.00012	CcSEcCtD
Entacapone—Abdominal pain—Pregabalin—epilepsy syndrome	2.48e-05	0.00012	CcSEcCtD
Entacapone—Body temperature increased—Pregabalin—epilepsy syndrome	2.48e-05	0.00012	CcSEcCtD
Entacapone—UGT1A9—Metabolism—KCNJ11—epilepsy syndrome	2.48e-05	0.000515	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—CHRM3—epilepsy syndrome	2.48e-05	0.000515	CbGpPWpGaD
Entacapone—Dry mouth—Topiramate—epilepsy syndrome	2.47e-05	0.00012	CcSEcCtD
Entacapone—Constipation—Gabapentin—epilepsy syndrome	2.46e-05	0.000119	CcSEcCtD
Entacapone—Pain—Gabapentin—epilepsy syndrome	2.46e-05	0.000119	CcSEcCtD
Entacapone—Pruritus—Valproic Acid—epilepsy syndrome	2.46e-05	0.000119	CcSEcCtD
Entacapone—Confusional state—Topiramate—epilepsy syndrome	2.44e-05	0.000118	CcSEcCtD
Entacapone—Oedema—Topiramate—epilepsy syndrome	2.42e-05	0.000117	CcSEcCtD
Entacapone—Shock—Topiramate—epilepsy syndrome	2.39e-05	0.000115	CcSEcCtD
Entacapone—Diarrhoea—Valproic Acid—epilepsy syndrome	2.38e-05	0.000115	CcSEcCtD
Entacapone—Nervous system disorder—Topiramate—epilepsy syndrome	2.38e-05	0.000115	CcSEcCtD
Entacapone—Feeling abnormal—Gabapentin—epilepsy syndrome	2.37e-05	0.000115	CcSEcCtD
Entacapone—Thrombocytopenia—Topiramate—epilepsy syndrome	2.37e-05	0.000115	CcSEcCtD
Entacapone—Gastrointestinal pain—Gabapentin—epilepsy syndrome	2.36e-05	0.000114	CcSEcCtD
Entacapone—Skin disorder—Topiramate—epilepsy syndrome	2.35e-05	0.000114	CcSEcCtD
Entacapone—Hyperhidrosis—Topiramate—epilepsy syndrome	2.34e-05	0.000113	CcSEcCtD
Entacapone—Hypersensitivity—Pregabalin—epilepsy syndrome	2.32e-05	0.000112	CcSEcCtD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	2.31e-05	0.00048	CbGpPWpGaD
Entacapone—Anorexia—Topiramate—epilepsy syndrome	2.31e-05	0.000112	CcSEcCtD
Entacapone—Dizziness—Valproic Acid—epilepsy syndrome	2.3e-05	0.000111	CcSEcCtD
Entacapone—Urticaria—Gabapentin—epilepsy syndrome	2.29e-05	0.000111	CcSEcCtD
Entacapone—Body temperature increased—Gabapentin—epilepsy syndrome	2.28e-05	0.00011	CcSEcCtD
Entacapone—Abdominal pain—Gabapentin—epilepsy syndrome	2.28e-05	0.00011	CcSEcCtD
Entacapone—Hypotension—Topiramate—epilepsy syndrome	2.27e-05	0.00011	CcSEcCtD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	2.26e-05	0.00047	CbGpPWpGaD
Entacapone—Asthenia—Pregabalin—epilepsy syndrome	2.25e-05	0.000109	CcSEcCtD
Entacapone—Pruritus—Pregabalin—epilepsy syndrome	2.22e-05	0.000108	CcSEcCtD
Entacapone—Vomiting—Valproic Acid—epilepsy syndrome	2.21e-05	0.000107	CcSEcCtD
Entacapone—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	2.21e-05	0.000107	CcSEcCtD
Entacapone—COMT—Metabolism—HMOX1—epilepsy syndrome	2.2e-05	0.000456	CbGpPWpGaD
Entacapone—Insomnia—Topiramate—epilepsy syndrome	2.19e-05	0.000106	CcSEcCtD
Entacapone—Rash—Valproic Acid—epilepsy syndrome	2.19e-05	0.000106	CcSEcCtD
Entacapone—Dermatitis—Valproic Acid—epilepsy syndrome	2.19e-05	0.000106	CcSEcCtD
Entacapone—Headache—Valproic Acid—epilepsy syndrome	2.18e-05	0.000105	CcSEcCtD
Entacapone—Paraesthesia—Topiramate—epilepsy syndrome	2.18e-05	0.000105	CcSEcCtD
Entacapone—COMT—Metabolism—CAT—epilepsy syndrome	2.17e-05	0.00045	CbGpPWpGaD
Entacapone—Dyspnoea—Topiramate—epilepsy syndrome	2.16e-05	0.000105	CcSEcCtD
Entacapone—Somnolence—Topiramate—epilepsy syndrome	2.16e-05	0.000104	CcSEcCtD
Entacapone—Diarrhoea—Pregabalin—epilepsy syndrome	2.15e-05	0.000104	CcSEcCtD
Entacapone—Dyspepsia—Topiramate—epilepsy syndrome	2.13e-05	0.000103	CcSEcCtD
Entacapone—Hypersensitivity—Gabapentin—epilepsy syndrome	2.12e-05	0.000103	CcSEcCtD
Entacapone—COMT—Metabolism—ABCB1—epilepsy syndrome	2.11e-05	0.000437	CbGpPWpGaD
Entacapone—Decreased appetite—Topiramate—epilepsy syndrome	2.11e-05	0.000102	CcSEcCtD
Entacapone—Gastrointestinal disorder—Topiramate—epilepsy syndrome	2.09e-05	0.000101	CcSEcCtD
Entacapone—Fatigue—Topiramate—epilepsy syndrome	2.09e-05	0.000101	CcSEcCtD
Entacapone—Dizziness—Pregabalin—epilepsy syndrome	2.08e-05	0.000101	CcSEcCtD
Entacapone—Pain—Topiramate—epilepsy syndrome	2.07e-05	0.0001	CcSEcCtD
Entacapone—Constipation—Topiramate—epilepsy syndrome	2.07e-05	0.0001	CcSEcCtD
Entacapone—Asthenia—Gabapentin—epilepsy syndrome	2.07e-05	0.0001	CcSEcCtD
Entacapone—Nausea—Valproic Acid—epilepsy syndrome	2.06e-05	9.99e-05	CcSEcCtD
Entacapone—Pruritus—Gabapentin—epilepsy syndrome	2.04e-05	9.86e-05	CcSEcCtD
Entacapone—UGT1A9—Metabolism—ABCG2—epilepsy syndrome	2.02e-05	0.00042	CbGpPWpGaD
Entacapone—Vomiting—Pregabalin—epilepsy syndrome	2e-05	9.67e-05	CcSEcCtD
Entacapone—Feeling abnormal—Topiramate—epilepsy syndrome	2e-05	9.67e-05	CcSEcCtD
Entacapone—Gastrointestinal pain—Topiramate—epilepsy syndrome	1.98e-05	9.59e-05	CcSEcCtD
Entacapone—Rash—Pregabalin—epilepsy syndrome	1.98e-05	9.59e-05	CcSEcCtD
Entacapone—Dermatitis—Pregabalin—epilepsy syndrome	1.98e-05	9.58e-05	CcSEcCtD
Entacapone—Diarrhoea—Gabapentin—epilepsy syndrome	1.97e-05	9.54e-05	CcSEcCtD
Entacapone—UGT1A9—Metabolism—CYP2C19—epilepsy syndrome	1.97e-05	0.000409	CbGpPWpGaD
Entacapone—Headache—Pregabalin—epilepsy syndrome	1.97e-05	9.53e-05	CcSEcCtD
Entacapone—COMT—Metabolism—GPX1—epilepsy syndrome	1.96e-05	0.000407	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—CYP11A1—epilepsy syndrome	1.96e-05	0.000407	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.95e-05	0.000404	CbGpPWpGaD
Entacapone—Urticaria—Topiramate—epilepsy syndrome	1.93e-05	9.32e-05	CcSEcCtD
Entacapone—Body temperature increased—Topiramate—epilepsy syndrome	1.92e-05	9.27e-05	CcSEcCtD
Entacapone—Abdominal pain—Topiramate—epilepsy syndrome	1.92e-05	9.27e-05	CcSEcCtD
Entacapone—Dizziness—Gabapentin—epilepsy syndrome	1.91e-05	9.22e-05	CcSEcCtD
Entacapone—Nausea—Pregabalin—epilepsy syndrome	1.87e-05	9.03e-05	CcSEcCtD
Entacapone—Vomiting—Gabapentin—epilepsy syndrome	1.83e-05	8.87e-05	CcSEcCtD
Entacapone—Rash—Gabapentin—epilepsy syndrome	1.82e-05	8.79e-05	CcSEcCtD
Entacapone—Dermatitis—Gabapentin—epilepsy syndrome	1.82e-05	8.78e-05	CcSEcCtD
Entacapone—Headache—Gabapentin—epilepsy syndrome	1.81e-05	8.74e-05	CcSEcCtD
Entacapone—Hypersensitivity—Topiramate—epilepsy syndrome	1.79e-05	8.64e-05	CcSEcCtD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.77e-05	0.000368	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—CYP2D6—epilepsy syndrome	1.77e-05	0.000367	CbGpPWpGaD
Entacapone—Asthenia—Topiramate—epilepsy syndrome	1.74e-05	8.42e-05	CcSEcCtD
Entacapone—COMT—Metabolism—AGT—epilepsy syndrome	1.72e-05	0.000356	CbGpPWpGaD
Entacapone—Pruritus—Topiramate—epilepsy syndrome	1.72e-05	8.3e-05	CcSEcCtD
Entacapone—Nausea—Gabapentin—epilepsy syndrome	1.71e-05	8.28e-05	CcSEcCtD
Entacapone—UGT1A9—Metabolism—ADRA2A—epilepsy syndrome	1.68e-05	0.000349	CbGpPWpGaD
Entacapone—COMT—Metabolism—APOE—epilepsy syndrome	1.68e-05	0.000349	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—BCHE—epilepsy syndrome	1.68e-05	0.000348	CbGpPWpGaD
Entacapone—Diarrhoea—Topiramate—epilepsy syndrome	1.66e-05	8.03e-05	CcSEcCtD
Entacapone—Dizziness—Topiramate—epilepsy syndrome	1.6e-05	7.76e-05	CcSEcCtD
Entacapone—UGT1A9—Metabolism—SLC2A1—epilepsy syndrome	1.6e-05	0.000332	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—PLCB1—epilepsy syndrome	1.58e-05	0.000328	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—TH—epilepsy syndrome	1.58e-05	0.000327	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.55e-05	0.000322	CbGpPWpGaD
Entacapone—Vomiting—Topiramate—epilepsy syndrome	1.54e-05	7.46e-05	CcSEcCtD
Entacapone—Rash—Topiramate—epilepsy syndrome	1.53e-05	7.4e-05	CcSEcCtD
Entacapone—Dermatitis—Topiramate—epilepsy syndrome	1.53e-05	7.39e-05	CcSEcCtD
Entacapone—Headache—Topiramate—epilepsy syndrome	1.52e-05	7.35e-05	CcSEcCtD
Entacapone—COMT—Metabolism—POMC—epilepsy syndrome	1.45e-05	0.0003	CbGpPWpGaD
Entacapone—Nausea—Topiramate—epilepsy syndrome	1.44e-05	6.97e-05	CcSEcCtD
Entacapone—COMT—Metabolism—ALB—epilepsy syndrome	1.32e-05	0.000274	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—HMOX1—epilepsy syndrome	1.32e-05	0.000273	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—CAT—epilepsy syndrome	1.3e-05	0.000269	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—ABCB1—epilepsy syndrome	1.26e-05	0.000262	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—GPX1—epilepsy syndrome	1.17e-05	0.000244	CbGpPWpGaD
Entacapone—COMT—Metabolism—PTGS2—epilepsy syndrome	1.15e-05	0.000239	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—AGT—epilepsy syndrome	1.03e-05	0.000214	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—APOE—epilepsy syndrome	1.01e-05	0.000209	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—POMC—epilepsy syndrome	8.66e-06	0.00018	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—ALB—epilepsy syndrome	7.9e-06	0.000164	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—PTGS2—epilepsy syndrome	6.91e-06	0.000143	CbGpPWpGaD
Entacapone—COMT—Metabolism—AKT1—epilepsy syndrome	5.8e-06	0.00012	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—AKT1—epilepsy syndrome	3.47e-06	7.21e-05	CbGpPWpGaD
